ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Sanofi says it will invest about $475 million annually in a new messenger RNA (mRNA) Center of Excellence, which will include about 400 employees across R&D and production sites in Cambridge, Massachusetts, and Lyon, France. Sanofi entered the mRNA vaccine field in 2018, when it formed a research pact with Translate Bio. The firms began clinical trials of vaccines for COVID-19 and influenza this year. Sanofi says it expects the center to yield six clinical candidates by 2025.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter